Chugai OTC Stock Valuation

CHGCF -  USA Stock  

USD 35.07  0.00  0.00%

What is the value of Chugai Pharmaceutical today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Chugai Pharmaceutical, is its stock price multiplied by the total number of shares outstanding, calculating Chugai Pharmaceutical's enterprise value requires a different approach. It uses Chugai Pharmaceutical's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Chugai Pharmaceutical shows a prevailing Real Value of $36.18 per share. The current price of the firm is $35.07. At this time, the firm appears to be fairly valued. Our model approximates the value of Chugai Pharmaceutical from analyzing the firm fundamentals such as Profit Margin of 28.50 %, return on equity of 23.55 %, and Current Valuation of (326.94 B) as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Chugai Valuation 

 
Refresh
Chugai Pharmaceutical Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Chugai Pharmaceutical's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Fairly Valued
Today
35.07
18th of October 2021
Share
Please note that Chugai Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Chugai Pharmaceutical is based on 3 months time horizon. Increasing Chugai Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Chugai Pharmaceutical is useful when determining the fair value of the Chugai otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Chugai Pharmaceutical. Since Chugai Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chugai OTC Stock. However, Chugai Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
36.18
Real Value
37.48
Upside
Estimating the potential upside or downside of Chugai Pharmaceutical helps investors to forecast how Chugai otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chugai Pharmaceutical more accurately as focusing exclusively on Chugai Pharmaceutical's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
35.0737.0841.12
Details
Hype
Prediction
LowEstimated ValueHigh
33.7735.0736.37
Details
Potential
Annual Dividend
LowIncome Per ShareHigh
4.165.146.12
Details

Chugai Pharmaceutical Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Chugai Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Chugai Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chugai Pharmaceutical competition to find correlations between indicators driving Chugai Pharmaceutical's intrinsic value. More Info.
Chugai Pharmaceutical is rated fifth in price to sales category among related companies. It is rated third in beta category among related companies totaling about  8.86  of Beta per Price to Sales.

About Chugai Pharmaceutical Valuation

The equity valuation mechanism determines the current worth of Chugai Pharmaceutical on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Chugai Pharmaceutical. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Chugai Pharmaceutical based exclusively on its fundamental and basic technical indicators. By analyzing Chugai Pharmaceutical's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Chugai Pharmaceutical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chugai Pharmaceutical. We calculate exposure to Chugai Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chugai Pharmaceutical's related companies.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7555 people.

Chugai Pharmaceutical Dividends Analysis For Valuation

There are various types of dividends Chugai Pharmaceutical can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Chugai shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Chugai Pharmaceutical directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Chugai pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Chugai Pharmaceutical by the value of the dividends paid out.

Chugai Pharmaceutical Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Chugai Pharmaceutical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio3.08
Earnings Quarterly Growth39.30%
Revenue Growth17.30%
Payout Ratio39.24%
Enterprise Value To Ebitda-0.93
Earnings Growth39.40%
Enterprise Value To Revenue-0.40
Continue to Trending Equities. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Chugai OTC Stock analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
The market value of Chugai Pharmaceutical is measured differently than its book value, which is the value of Chugai that is recorded on the company's balance sheet. Investors also form their own opinion of Chugai Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Chugai Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chugai Pharmaceutical's market value can be influenced by many factors that don't directly affect Chugai Pharmaceutical underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.